Vergoeding 2018-2022 voor ATC-subgroep A16AX : Diverse maagdarmkanaal- en metabolismeproducten
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| A16AX03 Fenylboterzuur (Ammonaps ®) | 388.800 | 219.770 | 209.280 | 187.920 | 213.170 |
| A16AX04 Nitisinon (Orfadin ®) | 2.317.700 | 2.193.800 | 2.043.000 | 1.688.700 | 1.684.800 |
| A16AX05 Zinkacetaat (Wilzin ®) | 70.205 | 78.243 | 79.175 | 79.544 | 85.054 |
| A16AX06 Miglustat (Zavesca ®) | 1.627.900 | 1.591.800 | 1.478.600 | 1.280.000 | 943.870 |
| A16AX07 Sapropterine (Kuvan ®) | 6.342.700 | 6.713.600 | 6.659.200 | 6.875.200 | 7.381.400 |
| A16AX09 Glycerolfenylbutyraat (Ravicti ®) | 96.581 | 442.250 | 592.700 | 678.480 | 960.520 |
| A16AX10 Eliglustat (Cerdelga ®) | 2.461.000 | 2.167.400 | 2.186.100 | . | . |
| A16AX11 Benzoaat natrium | 56.370 | 68.252 | 83.278 | 88.264 | 80.580 |
| A16AX12 Trientine (Cuprior ®) | . | . | 519.330 | 1.529.200 | 1.670.600 |
| A16AX15 Telotristat (Xermelo ®) | 28.596 | 226.890 | 307.990 | 328.790 | 391.060 |
| A16AX16 Givosiran (Givlaari ®) | . | . | . | 288.610 | 2.199.300 |
| Totaal | 13.389.852 | 13.702.005 | 14.158.653 | 13.024.708 | 15.610.354 |